Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-25
DOI
10.1038/s41598-020-62190-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
- (2019) Yang Yang et al. Cell Death & Disease
- NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
- (2018) Alena Grebe et al. CIRCULATION RESEARCH
- Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
- (2018) Paul M Ridker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes
- (2018) Brendan M. Everett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- Visfatin induces the apoptosis of endothelial progenitor cells via the induction of pro-inflammatory mediators through the NF-κB pathway
- (2017) Lina Sun et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- The immunology of atherosclerosis
- (2017) Anton Gisterå et al. Nature Reviews Nephrology
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus
- (2017) Concepción Peiró et al. Frontiers in Pharmacology
- Determinants of visfatin in type 2 diabetes patients with diabetic kidney disease: Relationship to inflammation, adiposity and undercarboxylated osteocalcin
- (2016) Alex C. Kacso et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure: Table 1.
- (2015) Charalampos I. Liakos et al. AMERICAN JOURNAL OF HYPERTENSION
- Regulation of inflammasome activation
- (2015) Si Ming Man et al. IMMUNOLOGICAL REVIEWS
- Instigation of endothelial Nlrp3 inflammasome by adipokine visfatin promotes inter-endothelial junction disruption: role of HMGB1
- (2015) Yang Chen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Plasma visfatin/nicotinamide phosphoribosyltransferase levels in hypertensive elderly – results from the PolSenior substudy
- (2015) Piotr Kocelak et al. Journal of the American Society of Hypertension
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Unique Toll-Like Receptor 4 Activation by NAMPT/PBEF Induces NFκB Signaling and Inflammatory Lung Injury
- (2015) Sara M. Camp et al. Scientific Reports
- Endothelial NLRP3 Inflammasome Activation and Enhanced Neointima Formation in Mice by Adipokine Visfatin
- (2014) Min Xia et al. AMERICAN JOURNAL OF PATHOLOGY
- The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
- (2014) Susana Vallejo et al. Cardiovascular Diabetology
- Mechanisms and Functions of Inflammasomes
- (2014) Mohamed Lamkanfi et al. CELL
- Endotoxin-induced vascular endothelial cell migration is dependent on TLR4/NF-κB pathway, NAD(P)H oxidase activation, and transient receptor potential melastatin 7 calcium channel activity
- (2014) Daniela Sarmiento et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Visfatin/Nampt induces telomere damage and senescence in human endothelial cells
- (2014) Laura A. Villalobos et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Inflammasomes: Molecular Regulation and Implications for Metabolic and Cognitive Diseases
- (2014) Alexander J.S. Choi et al. MOLECULES AND CELLS
- NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
- (2014) Beibei Luo et al. PLoS One
- Visfatin/Nampt: An Adipokine with Cardiovascular Impact
- (2013) Tania Romacho et al. MEDIATORS OF INFLAMMATION
- Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells
- (2013) Tania Romacho et al. PLoS One
- Effect of interleukin 1β inhibition in cardiovascular disease
- (2012) Arman Qamar et al. CURRENT OPINION IN LIPIDOLOGY
- Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus
- (2012) SEMA USLU et al. Experimental and Therapeutic Medicine
- Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review
- (2011) Yu-Hung Chang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Visfatin Impairs Endothelium-Dependent Relaxation in Rat and Human Mesenteric Microvessels through Nicotinamide Phosphoribosyltransferase Activity
- (2011) Susana Vallejo et al. PLoS One
- Membrane raft–lysosome redox signalling platforms in coronary endothelial dysfunction induced by adipokine visfatin
- (2010) Min Xia et al. CARDIOVASCULAR RESEARCH
- Visfatin/PBEF/Nampt: A New Cardiovascular Target?
- (2010) Concepción Peiró et al. Frontiers in Pharmacology
- Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo
- (2009) Laura Formentini et al. BIOCHEMICAL PHARMACOLOGY
- Endothelial Dysfunction
- (2009) Paul M. Vanhoutte CIRCULATION JOURNAL
- Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans
- (2009) Sheng Wen Liu et al. CLINICAL ENDOCRINOLOGY
- Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity
- (2009) T. Romacho et al. DIABETOLOGIA
- Visfatin (Nampt) and Ghrelin as Novel Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes
- (2009) N. P. E. Kadoglou et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide
- (2008) Pei Wang et al. CARDIOVASCULAR RESEARCH
- Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD
- (2008) Nathalie Busso et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now